Alphatec Holdings, Inc.

NasdaqGS ATEC

Alphatec Holdings, Inc. Market Capitalization on January 14, 2025: USD 1.58 B

Alphatec Holdings, Inc. Market Capitalization is USD 1.58 B on January 14, 2025, a -24.76% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Alphatec Holdings, Inc. 52-week high Market Capitalization is USD 2.34 B on February 09, 2024, which is 48.18% above the current Market Capitalization.
  • Alphatec Holdings, Inc. 52-week low Market Capitalization is USD 701.68 M on October 10, 2024, which is -55.49% below the current Market Capitalization.
  • Alphatec Holdings, Inc. average Market Capitalization for the last 52 weeks is USD 1.44 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGS: ATEC

Alphatec Holdings, Inc.

CEO Mr. Patrick S. Miles
IPO Date June 12, 2006
Location United States
Headquarters 1950 Camino Vida Roble
Employees 839
Sector Health Care
Industries
Description

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Similar companies

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

AORT

Artivion, Inc.

USD 29.68

1.16%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

GMED

Globus Medical, Inc.

USD 88.18

1.15%

SIBN

SI-BONE, Inc.

USD 15.70

-3.27%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email